双相障碍-分裂情感障碍-分裂症鉴别的生物学边界.ppt_第1页
双相障碍-分裂情感障碍-分裂症鉴别的生物学边界.ppt_第2页
双相障碍-分裂情感障碍-分裂症鉴别的生物学边界.ppt_第3页
双相障碍-分裂情感障碍-分裂症鉴别的生物学边界.ppt_第4页
双相障碍-分裂情感障碍-分裂症鉴别的生物学边界.ppt_第5页
已阅读5页,还剩21页未读, 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Informing DSM-5:Biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia,Victoria E Cosgrove and Trisha Suppes BMC Medicine 2013, 11:128,Figure 1. DSM-IV-TR features of bipolar I disorder, schizoaffective disorder, and schizophrenia.,Table 1 .Summary of key evide

2、nce at the forefront of the boundaries of schizophrenia, schizoaffective disorder, andbipolar I disorder debate,Table 2. Strength of evidence for biological factors supporting merging in some way schizophrenia, schizoaffective and bipolar I disorder,A hundred years ago, Kraepelin distinguished two t

3、ypes of “insanity” in his institutionalized patients: dementia praecox (later relabeled as schizophrenia) and manic-depressive illness (later relabeled as bipolar disorder). His dichotomy was based on differences in clinical features, course, and outcomes. But over the years, Kraepelin recognized an

4、d admitted that some patients have overlapping features, and he gradually accepted what is now seen as a continuum of psychosis that “bridges”( schizoaffective disorder) the pure forms of those two disorders.,Symptoms. Beyond a doubt, these two brain diseases have overlapping clinical features, phar

5、macotherapies,and even outcomes in a subgroup of patients. However, these diseases have major differences, as outlined in the accompanying table (page 68).,Brain anomalies. Neuroimaging studies indicate that schizophrenia is associated with more-severe and pervasive morphologic brain anomalies (dysp

6、lasia and hypoplasia) than bipolar disorder, although some bipolar patients have reduced cerebral and frontal volumes and marked cognitive deficits.3 Progressive neuro tissue loss has been observed early in schizophrenia but not in bipolar disorder. 3. Coffman JA, Bornstein RA, Olson SC, et al. Cogn

7、itive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry 1990;27(11):1188-96.,Recent genetic studies indicate that several genes are found exclusively in schizophrenia or in bipolar disorder cohorts,4 but some are shared by both disorders and may be related to delusional s

8、ymptoms.5 Familial transmission appears to differ: transgenerational studies find an abundance of mood disorders in family members of bipolar probands but relatively sparse occurrence of psychosis in families of probands with schizophrenia. 4. Weinberger DR. Genetic mechanisms of psychosis: in vivo

9、and postmortem genomics. Clin Ther 2005;27(suppl):8-15. 5. Schulze TG, Ohlfaun S, Czerski PM, et al. Arch Gen Psychiatry 2005;162:2101-8.,Candidate Genes in SchizophreniaBipolar Disorder Boundary,E.Ivleva, G. Thaker, C A. Tamminga. Comparing Genes and Phenomenology in the Major Psychoses:Schizophren

10、ia and Bipolar 1 Disorder. Schizophrenia Bulletin, 34(4), pp. 734742, 2008,Treatment. There is no doubt that monotherapy with antipsychotics (old and new) has similar efficacy6 in schizophrenia and bipolar mania (and even in bipolar depression, with some atypicals7). 6. Tandon R, Fleischhacker WW. C

11、omparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessment.Schizophr Res 2005;79:145-55. 7. Calabrese JR, Keck P Jr., McFadden W, et al: A randomized double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiat

12、ry 2005;162:1351-60.,However, there is minimal, if any, evidence that monotherapy mood stabilizers (lithium or anticonvulsants)have any tangible efficacy in schizophrenia. Electroconvulsive therapy is remarkably efficious in all phases of bipolar disorder but of dubious, if any, lasting benefit in s

13、chizophrenia.,Course. Both the premorbid history and posttreatment functional outcome tend to be more favorable in patients with bipolar disorder than schizophrenia. Most patients with schizophrenia experience significant clinical, social, and vocational deterioration, compared with a relative minor

14、ity of bipolar patients.,summary,schizophrenia and bipolar disorder are clearly distinct in their pure forms, although many patients have varying mixtures of both. Schizoaffective disorder is one of the most extensively investigated. Although many scholars have studied schizoaffective disorder, the

15、evidence defies lumping it with either end of the continuum.,I agree with Drs. Lake and Hurwitz that most cases of schizoaffective disorder, especially the “schizomanic” type, are probably bipolar disorder with severe psychotic features. To assert, however, that schizophrenia does not exist at all a

16、nd should be reclassified as bipolar disorder with psychotic features would contradict a massive body of clinical and biological evidence. It would cause Kraepelin to squirm in his grave.,抗精神病药物对肝功能的影响,本文通过查阅大量文献以及结合多年临床经验发现,几乎所有抗精神病药物均有导致肝功能损害的文献报道。其中典型抗精神病药物氯丙嗪及非典型抗精神病药物氯氮平对肝脏损害较常见。 阿立哌唑对肝功能的影响很小且易恢复,一般不需要根据患者的肝功能损害情况调整剂量。 齐拉西酮、氨磺必利对肝功能的影响很小,一般很少引起转氨酶明显升高,在临床治疗中对肝功能损伤的患者一般无需调整剂量。 毕玉萍, 罗小年. 常用抗精神病药物对肝功能影响的临床研究报道实录J. 中南药学, 2013, 11(2): 76-79.,Antidepressant-Induced Liver Injury Underestimated,基于对证据的回顾,造

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论